IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

60 Degrees Pharmaceuticals I

CUSIP: 83006G104 | 16 institutional holders

Quarters

Q4 2024Q2 2024Q1 2024Q4 2023Q3 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13GKnight Therapeutics Inc.658,62919.9%New 5%+ stakeJul 22, 2026No 13F filer matched
13GKnight Therapeutics Inc.658,629
19.9% of class · Jul 22, 2026

Institutional Holders — Q4 2024

Bogart Wealth, LLC700
0.0% of portfolio›$903
StyleTurnoverLocationFiled
Bogart Wealth, LLC
700$9030.0%GARPMediumMclean, VA2025-01-30
New 5%+ stake
No 13F filer matched